| Susan Celia Hellerstein, MD | |
|
111 Cypress St, Brookline, MA 02445-6002 | |
| (857) 307-0896 | |
| Not Available |
| Full Name | Susan Celia Hellerstein |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 111 Cypress St, Brookline, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013974492 | NPI | - | NPPES |
| 3063828 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 71207 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients' prognoses and select treatments that are most likely to benefit them.
A group of leading cardiac specialists has proposed new guidelines for the allocation of donor hearts to patients awaiting transplant. The changes are aimed at improving the organ distribution process to increase the survival rate of patients awaiting transplant and posttransplant.
Higher mortality rates among older adult asthma patients compared to their younger counterparts may be due, at least in part, to an increase in airway inflammation, according to a study conducted by researchers in Canada, who note that their results imply that elderly patients are either less likely to follow asthma medication dosing instructions, or that the underlying airway inflammation in elderly patients is relatively resistant to current anti-inflammatory therapies.
Elusys Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted for filing and review its Biologics License Application for Anthim® (obiltoxaximab) for the treatment and prevention of inhalational anthrax, a top bioterror threat which was submitted on March 20, 2015. Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government's repository of critical medical supplies for biowarfare preparedness.
› Verified 8 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients' prognoses and select treatments that are most likely to benefit them.
A group of leading cardiac specialists has proposed new guidelines for the allocation of donor hearts to patients awaiting transplant. The changes are aimed at improving the organ distribution process to increase the survival rate of patients awaiting transplant and posttransplant.
Higher mortality rates among older adult asthma patients compared to their younger counterparts may be due, at least in part, to an increase in airway inflammation, according to a study conducted by researchers in Canada, who note that their results imply that elderly patients are either less likely to follow asthma medication dosing instructions, or that the underlying airway inflammation in elderly patients is relatively resistant to current anti-inflammatory therapies.
Elusys Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted for filing and review its Biologics License Application for Anthim® (obiltoxaximab) for the treatment and prevention of inhalational anthrax, a top bioterror threat which was submitted on March 20, 2015. Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government's repository of critical medical supplies for biowarfare preparedness.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Celia Hellerstein, MD 850 Boylston St, Fish Women's Health Center, Chestnut Hill, MA 02467-2477 Ph: (617) 732-9300 | Susan Celia Hellerstein, MD 111 Cypress St, Brookline, MA 02445-6002 Ph: (857) 307-0896 |
News Archive
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
Researchers have identified a set of genetic abnormalities in patients with acute myelogenous leukemia (AML) that doctors can use to more accurately predict patients' prognoses and select treatments that are most likely to benefit them.
A group of leading cardiac specialists has proposed new guidelines for the allocation of donor hearts to patients awaiting transplant. The changes are aimed at improving the organ distribution process to increase the survival rate of patients awaiting transplant and posttransplant.
Higher mortality rates among older adult asthma patients compared to their younger counterparts may be due, at least in part, to an increase in airway inflammation, according to a study conducted by researchers in Canada, who note that their results imply that elderly patients are either less likely to follow asthma medication dosing instructions, or that the underlying airway inflammation in elderly patients is relatively resistant to current anti-inflammatory therapies.
Elusys Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted for filing and review its Biologics License Application for Anthim® (obiltoxaximab) for the treatment and prevention of inhalational anthrax, a top bioterror threat which was submitted on March 20, 2015. Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government's repository of critical medical supplies for biowarfare preparedness.
› Verified 8 days ago
Mark N Kaplan, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1180 Beacon St, Suite 3d, Brookline, MA 02446 Phone: 617-735-8990 | |
Dr. Lauren Elizabeth Ditrio, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 1 Brookline Pl Ste 620, Brookline, MA 02445 Phone: 617-735-8800 | |
Susan Mann, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1180 Beacon St Ste A, Brookline, MA 02446 Phone: 617-366-7711 Fax: 617-232-2055 | |
Kathleen F Thurmond, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12 Thorndike St, Brookline, MA 02446 Phone: 617-277-9753 | |
Carolyn A Cline, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: One Brookline Place, Suite 521, Brookline, MA 02445 Phone: 617-735-8800 Fax: 617-278-9358 | |
Dr. David Alden Ryley, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Brookline Pl Ste 302, Boston Ivf - The Boston Center, Brookline, MA 02445 Phone: 617-735-9000 Fax: 617-738-8993 |